Finally, through ligand-receptor interaction analysis, we identified a CD47-SIRPA-mediated phagocytic checkpoint between plasma and T cells, which suggests an immune surveillance defect with MM progression, and corresponds to clinical studies. This evidence concerns the gene SIRPA and Miyoshi myopathy.